These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 2118479

  • 1. Cytokine secretion effected by synergism of the immunomodulator AS101 and the protein kinase C inducer bryostatin.
    Sredni B, Kalechman Y, Albeck M, Gross O, Aurbach D, Sharon P, Sehgal SN, Gurwith MJ, Michlin H.
    Immunology; 1990 Aug; 70(4):473-7. PubMed ID: 2118479
    [Abstract] [Full Text] [Related]

  • 2. In vivo synergistic effect of the immunomodulator AS101 and the PKC inducer bryostatin.
    Kalechman Y, Albeck M, Sredni B.
    Cell Immunol; 1992 Aug; 143(1):143-53. PubMed ID: 1623562
    [Abstract] [Full Text] [Related]

  • 3. Effect of AS101 on bryostatin 1-mediated differentiation induction, cell cycle arrest, and modulation of drug-induced apoptosis in human myeloid leukemia cells.
    Rao AS, Freemerman AJ, Jarvis WD, Chelliah J, Bear HD, Mikkelsen R, Grant S.
    Leukemia; 1996 Jul; 10(7):1150-8. PubMed ID: 8683995
    [Abstract] [Full Text] [Related]

  • 4. Effect of the immunomodulator AS101 on chemotherapy-induced multilineage myelosuppression, thrombocytopenia, and anemia in mice.
    Kalechman Y, Rushkin G, Nerubay J, Albeck M, Sredni B.
    Exp Hematol; 1995 Dec; 23(13):1358-66. PubMed ID: 7498364
    [Abstract] [Full Text] [Related]

  • 5. Synergism between AS101 and PMA in lymphokine production.
    Sredni B, Kalechman Y, Shalit F, Albeck M.
    Immunology; 1990 Jan; 69(1):110-6. PubMed ID: 2107143
    [Abstract] [Full Text] [Related]

  • 6. Delay in the onset of systemic lupus erythematosus following treatment with the immunomodulator AS101: association with IL-10 inhibition and increase in TNF-alpha levels.
    Kalechman Y, Gafter U, Da JP, Albeck M, Alarcon-Segovia D, Sredni B.
    J Immunol; 1997 Sep 15; 159(6):2658-67. PubMed ID: 9300685
    [Abstract] [Full Text] [Related]

  • 7. Induction of acute phase proteins in mice and humans by treatment with AS101, an immunomodulator with radioprotective properties.
    Kalechman Y, Shani A, Albeck M, Sredni B.
    Immunopharmacology; 1995 Mar 15; 29(2):149-58. PubMed ID: 7539780
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Role of endogenous cytokines secretion in radioprotection conferred by the immunomodulator ammonium trichloro(dioxyethylene-0-0')tellurate.
    Kalechman Y, Zuloff A, Albeck M, Strassmann G, Sredni B.
    Blood; 1995 Mar 15; 85(6):1555-61. PubMed ID: 7888674
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Differential effect of the immunomodulator AS101 on B7-1 and B7-2 costimulatory molecules: role in the antitumoral effects of AS101.
    Kalechman Y, Sredni B.
    J Immunol; 1996 Jul 15; 157(2):589-97. PubMed ID: 8752906
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Co-induction of lymphokine synthesis by the antineoplastic bryostatins.
    Mohr H, Pettit GR, Plessing-Menze A.
    Immunobiology; 1987 Nov 15; 175(5):420-30. PubMed ID: 3123367
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Radioprotective effects of the immunomodulator AS101.
    Kalechman Y, Albeck M, Oron M, Sobelman D, Gurwith M, Seghal SN, Sredni B.
    J Immunol; 1990 Sep 01; 145(5):1512-7. PubMed ID: 2384668
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Expansion and tumour specific cytokine secretion of bryostatin-activated T-cells from cryopreserved axillary lymph nodes of breast cancer patients.
    Lind DS, Tuttle TM, Bethke KP, Frank JL, McCrady CW, Bear HD.
    Surg Oncol; 1993 Oct 01; 2(5):273-82. PubMed ID: 8305969
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.